{"name":"Odyssey Therapeutics","slug":"odyssey-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNclVFQ0pjVWtFdkZRNHdSTjBPd1B3bXZqYzhWQnZSUTVIemE3ZEVPUVI5Z2N2Mks0aEpDZXdDWHpIZVZzVHhzY0lfd3V4c3p4bEF0ZjVpcVAxLVJ2YVhWWnhxOHBlR0I3RkZoeld4cTdtWFVSSExJNEV6Vk1TLVpCVktkVDJCVmFBMjU1bDgyX1ZIQ0pKd1cwV2RuVXctYjBabEk4d0QxYVJvb0NmQTFpT0hzRTVIeTFteERKNDdqLThjcGZsT0pCUHVZeVBNZm4tVlozUw?oc=5","date":"2026-03-10","type":"pipeline","source":"Business Wire","summary":"Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board - Business Wire","headline":"Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPQUhVeDgwd1RwTHdkQTVEem5Zc1VOck85Z3VuRXJoOVFhTGdWd3J6MnJFTVNEZDFBSk43Q0VfUDV1aUhqOGJ0Q19mNGo0RFBhMllsNUU5SGpsUVowT01NMjZIUlZSYXJsNkRFRG9LbWVsZlNyd1pkRkNKOFBJMkI0MUluRFF4V3hLSFQ1c1prcFdNd0tmS2ZRMGUtaG1yTTc3QS1ybDZidFBuYTVFRWE0dFB3?oc=5","date":"2026-01-21","type":"pipeline","source":"Contract Pharma","summary":"Odyssey Therapeutics Appoints Jolie Siegel EVP and General Counsel - Contract Pharma","headline":"Odyssey Therapeutics Appoints Jolie Siegel EVP and General Counsel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQQl9kUUFCSjY1UlM3QlNxY0xlQklVR0J6d3VyVXNCelE2YVZyczBlSHVqWkpLLXdHazhzUVgtaFpoMnBUZzJkejJnRnhVTlM0Y3JSMnZMUGhOXzE3VkVlUmVTWDdsSjlXOHd4V0hqb0ZVbThLYmtzMFRiSGVjbXNhWlFnZmZXRGgwcEFpTWpRZ0hGdGhQREU1VVpMYXJTOVlEb1pmWmJyZFc2NHpmbExhV0IzeEtBcjg0VFJ6UTBkbERoaE5obVE?oc=5","date":"2025-11-11","type":"pipeline","source":"Contract Pharma","summary":"Odyssey Therapeutics Taps Dennis Dean as EVP and Head of Non-Clinical Development - Contract Pharma","headline":"Odyssey Therapeutics Taps Dennis Dean as EVP and Head of Non-Clinical Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQN2RHSTBJM0hVbl9sWXhvSUlsaUtXWlh2NFdQeVY4OW9jMHlUU0d5VFUxMVY2bVV2OE05WFBQRWlJVGp5dGd2SXpjUXRVRzVzYXZOTDlxb20zdVlISVJORGRDeUduRzJndmpYUi0tYi1nQThRUVF0WGs2YXJrdWxpMXpFdXJucTlvcGJGajhGREhsbHlXYVozT1FrNm95V0RLekx3ZC1xM2pWU0hKdlFCUFRyZlhhRllOaHljYnRyeDZsaDdvNXJFM1hJRnJMYmtMdVZ6NHlNdUduUzdlN0VUY2xQZWYzS2dHX1dBMTI1UWd0Q0JKRVdTeg?oc=5","date":"2025-11-11","type":"pipeline","source":"Business Wire","summary":"Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development - Business Wire","headline":"Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPS0ZEVlJyckhQUUhZNEhud0tpLXVTbTdVSjNmNkw2NkV3YnB4U29CWUlDSGNhOGNFcjdmdjM1SFhUSVE2Z2VTakZMVm5fQ29NZ2FHcFI4Zzc4MTZYWXJYWktGVm5yaDVZU2FyWDAxbVEyajRtaGREWWVFZThaQlBhdXhjVTJVNFBGQ2R5YXpLOVpxb2NsakowLUt6SmNZTXRqNWswMHlzSktDdDI5MnFJa29LWTlWQ2d1cmV6cVktZ0NDS2hCMzEtdFdka2Eydw?oc=5","date":"2025-10-10","type":"pipeline","source":"BioSpace","summary":"Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors - BioSpace","headline":"Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxObHZOQ2ZESXFvdGJDcEtfRmlmTTgyb004RExma2t6RDMwaFJmdlZxSFBldk9Ndk1qSFhnZTkwcEtNWnp6SEpJa2N3UF8xR1A4UklIam84LUEybDFkNE55N2FWVEdnS2RNbHBVY2ExT1dQdDh5Yk90dkxyLWJIaWhpaEJGRzVycDI3dXR5UG9vOWxtSUtJSEEyT3dRZGl0UEtUMF8tZXBR?oc=5","date":"2025-09-11","type":"pipeline","source":"The Pharma Letter","summary":"Odyssey Therapeutics closes $213 million Series D financing - The Pharma Letter","headline":"Odyssey Therapeutics closes $213 million Series D financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5RM05DVVFySjB3bmc1ZDJpeFI4ZklHcHZIQnBYYmRzaHZ2cGNRMGxhZFNpbjdRTklZRXRTS2VFZE9jNWt6VWQ5SkNuOWdjY3dGVndMQ2JWQWpNeHQ1LUNqclZB?oc=5","date":"2025-09-11","type":"pipeline","source":"The Pharma Letter","summary":"Odyssey Therapeutics - The Pharma Letter","headline":"Odyssey Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE53MEJRRVg1QXQwU2RNOXJYT1E4ZEZ5cUpmcjhJUHNlZXFvblRsb0pRdlZmV0g3QlNuaDRYTXFiWEg2ZE5BWFpMRC1XWnVVWlA2Q2hj?oc=5","date":"2025-09-10","type":"pipeline","source":"FirstWord Pharma","summary":"Biopharma megarounds: Kriya and Odyssey raise over half a billion in venture financings - FirstWord Pharma","headline":"Biopharma megarounds: Kriya and Odyssey raise over half a billion in venture financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPUVpRdUZ3MFpMT3BZNTBSU1l0OHJTU3FFVnBVdGRrSUNZN2xqYm1lZnFJby03QUtlLUVOTEh2VkFIeVNSYjJsaXRzYXNxTWhoakRzUXlUZi1mU0M3QzRNTUppY05SY3h2Vk5mSTBlWUxmY2VCTGo5ZFE4VTl5Wm5kVVRnQThlZW9hRDFzSg?oc=5","date":"2025-09-10","type":"pipeline","source":"BioSpace","summary":"Odyssey Rebounds Off Failed IPO With $213M Series D - BioSpace","headline":"Odyssey Rebounds Off Failed IPO With $213M Series D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1FaHAxdmFiQ1JmR0FHLUxtOVF4UmxTT19NRXMzMGI2ZV9kd3R1UE1CS01UVG9PNVlOQ2R2TFRSUGNldEJvcXZFa20zM1lqUmp0dUoxRkgxWXU1bWlwWnM2OFBxS05ycm9mel9jTkRUYVZLdW4wdE5R?oc=5","date":"2025-09-10","type":"pipeline","source":"statnews.com","summary":"Trump reportedly discussing crackdown on Chinese drugs - statnews.com","headline":"Trump reportedly discussing crackdown on Chinese drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxORk5NOHRwb3NQd0xtaGtYMFdadGVfSUtiZEhBV2FTUHJ2SHRxVXFzWlV1ZnZRT3RXYlJqVU1Zb3pWTHc3dWUyOU5fdlE2ZkRkTE12YTNjVWctblZlbUM3UXkwS1NUZmozSEVpSGF0OGRBR1NhZjdoYnRKcVBmRHlTRGptbWZOV3YzR0w0dlhfdjlUekN4c0VhZUlfYklTZzJfbnIyVzV3NDlqUkpXZjNBVA?oc=5","date":"2025-06-10","type":"pipeline","source":"Fierce Biotech","summary":"Odyssey abandons IPO plans in latest sign of tough environment for biotech listings - Fierce Biotech","headline":"Odyssey abandons IPO plans in latest sign of tough environment for biotech listings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNc2dEZndTaEFnajUxTXZfOGlJeFF6bE1jRm9rUTFteVB5RXNWTVhhdmhRMnFkUHkxY1h6ZVc2WVNieFF6UWhVTHVPaVlWeVVtMUVzNmRZeWxKcFNmaUpQS0NXVWpIUzlnOHY1SzdsZC0tTzdTcl9HeF9BS3dpVFk3WmR0VzROLUdmeDRpZjEyX0hSQlZhc3ZsdF83a081LUFLbDhrV0czUlFOOVNJ?oc=5","date":"2025-06-10","type":"pipeline","source":"Pharmaceutical Technology","summary":"Odyssey bails on public listing as US IPO landscape stutters - Pharmaceutical Technology","headline":"Odyssey bails on public listing as US IPO landscape stutters","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}